News Notification

Intensive Review of Nephrology 2023

487 views Tags: CME Brigham Board Review

Board Prep, Best Practices and More

With 90+ lectures, case discussions, and board preparation sessions, this online CME program is an indispensable and comprehensive review of state-of-the-art nephrology practices offered by the clinical faculty of Harvard Medical School.

Intensive Review of Nephrology also offers board review practice sessions and board-relevant Q&As, with a particular focus on acid-base and electrolyte disorders, glomerulonephritis, transplantation, renal pathology, and clinical images. Plus, you get valuable continuing medical education insight on:

  • Genetic testing for improved prognosis and therapy selection
  • Introduction to point-of-care ultrasound: fundamentals for acquisition and interpretation
  • Physical exam of the dialysis access
  • Expanding the role of SGLT2i in diabetic and non-diabetic kidney disease
  • Cases in crypto nephrology
  • The new fundamentals in immunology and nephrology (it’s not just for transplant patients)

* Date of Original Release: September 30, 2022

* Termination Date: January 31, 2025

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Summarize current/recommended nephrology guidelines in clinical practice
  • Explain the differential diagnosis of complex clinical presentations of patients with renal disorders
  • Identify/integrate current therapeutic options for specific renal disorders
  • Review and interpret up-to-date literature relevant to clinical practice
  • Describe pathophysiological mechanisms as they apply to the management of renal disease
  • Synthesize teachings to better performance on the ABIM nephrology certification/recertification

INTENSIVE REVIEW of NEPHROLOGY 2023

0 0 votes
Article Rating

INTENSIVE REVIEW of NEPHROLOGY 2023 TOPICS

1. Renal Physiology for the Boards – Melanie P. Hoenig, MD

2. Basic Concepts of Immunology in Autoimmune Kidney Disease – Ramon G. Bonegio, MD

3. Question and Answer Session – Faculty

4. Renal Pathology in 2022 – Part 1 Nephritic Condition – Helmut G. Rennke, MD

5. Renal Pathology in 2022 – Part 2 – Astrid Weins, MD, PhD

6. Current Approaches to Urine Sediment Analysis – Martina M. McGrath, MB BCh

7. Question and Answer Session – Faculty

8. IgA Nephropathy – Gerald B. Appel, MD

9. Membranous Nephropathy – Laurence H. Beck, Jr., MD, PhD

10. ANCA Vasculitis – John L. Niles, MD

11. Question and Answer Session – Faculty

12. Update on Lupus Nephritis – Gerald B. Appel, MD

13. Metabolic Management of Kidney Stones – Gary Curhan, MD, ScD

14. Anemia Management: Update and Best Practices – Ajay K. Singh, MBBS, FRCP (UK), MBA

15. Question and Answer Session – Faculty

16. Hyponatremia and Hypernatremia – Sodium Disorders – David B. Mount, MD

17. Hypokalemia and Hyperkalemia – Potassium Disorders – David B. Mount, MD

18. Question and Answer Session – Faculty

19. Acid-Base Disorders Part I – Anion Gap Metabolic Acidosis – Alan S.L. Yu, MB, BChir

20. Acid-Base Disorders II – Non-Gap Acidosis and Metabolic Alkalosis – Alan S.L. Yu, MB, BChir

21. Question and Answer Session – Faculty

22. Treating Renal Patients with Rituximab in the Era of Covid-19 – David B. Mount, MD

23. Genetics and Kidney Disease – Friedhelm Hildebrandt, MD

24. Update on Polycystic Kidney Disease – Cristian Riella, MD

25. Question and Answer Session – Faculty

26. Pediatric Nephrology – Michael J.G. Somers, MD

27. Genetics – How to Integrate It into Practice – Ana Onuchic-Whitford, MD

28. Health Disparities in Chronic Kidney Disease – Lupus Nephritis as a Model Social Determinants, Biology, and Unmet Needs – Winfred W. Williams, Jr., MD

29. SPECIAL LECTURE — Pig-to-Human Xenotransplantation: NYU Langone Health’s Experience – Robert Montgomery, MD, PhD

30. Why Do We Reject a Transplant? – Jamil R. Azzi, MD

31. Transplant Immunosuppression for the Boards – Steven Gabardi, PharmD, BCPS, FAST, FCCP

32. Question and Answer Session – Faculty

33. Immunological Assessment Pre and Post Transplant – Melissa Y. Yeung, MD and Indira Guleria, PhD

34. Early Post-Transplant Management – Anil K. Chandraker, MD

35. Question and Answer Session – Faculty

36. Evaluation of the Kidney Living Donor – Kassem Safa, MD

37. Late Loss of the Kidney Transplant – Andrew S. Allegretti, MD, MSc

38. Infections in Transplant Recipients – Sarah P. Hammond, MD

39. Monitoring Kidney Transplant Patients: Beyond Creatinine – Saif Abdulkarim Muhsin, MB BCh

40. Pre-Transplant Surgical Evaluation of Recipients – Jamil R. Azzi, MD

41. Question and Answer Session – Faculty

42. Poisonings and Intoxications: What a Nephrologist Needs to Know – Timothy B. Erickson, MD

43. Late Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD

44. Hemolytic Uremic Syndrome (HUS) and Thrombotic Thrombocytopenic Purpura (TTP) – Jean M. Francis, MD

45. Geriatric Nephrology – Ernest I. Mandel, MD

46. Pathophysiology and Treatment of Diabetic Kidney Disease – Gearoid M. McMahon, MB BCh

47. Management of Hypertension after SPRINT – A Plethora of Guidelines – Richard J. Glassock, MD

48. Question and Answer Session – Faculty

49. Secondary Hypertension – Primary Aldosteronism and Pheochromocytoma – Anand Vaidya, MD, MMSc

50. Cardiorenal Syndrome – Finnian R. McCausland, MB BCh, MMSc, FRCPI

51. Liver and the Kidney – Andrew S. Allegretti, MD, MSc

52. Question and Answer Session – Faculty

53. Pathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD

53. Acute Kidney Injury Syndromes – Alice M. Sheridan, MD

55. ICU Nephrology and Continuous Renal Replacement Therapies – David J.R. Steele, MB BCh

56. Question and Answer Session – Faculty

57. Cancer and Acute Kidney Injury – Albert Q. Lam, MD

58. Paraprotein-Induced Kidney Injury – Albert Q. Lam, MD

59. Focal and Segmental Glomerulosclerosis (FSGS): A Lesion, Not a Disease – Richard J. Glassock, MD

60. From Genes to Therapies – Anna Greka, MD, PhD

61. APOL1 and Kidney Disease – Opeyemi Olabisi, MD, PhD

62. Question and Answer Session – Faculty

63. Dialysis Dosing – J. Kevin Tucker, MD

64. Mineral and Bone Disease – David Bushinsky, MD

65. Question and Answer Session – Faculty

66. Dialysis – A Case-Based Clinical Review and Update – J. Kevin Tucker, MD

67. Pearls in Mineral and Bone Disease – David Bushinsky, MD

68. Chronic Kidney Disease Epidemiology – A 2022 Update – Gearoid M. McMahon, MB BCh

69. Question and Answer Session – Faculty

70. Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC

71. Peritoneal Dialysis Complications – Joanne M. Bargman, MD, FRCPC

72. Peritoneal Dialysis: Audience Questions Answered – J. Kevin Tucker, MD

73. Acute Kidney Injury Related to Immune Checkpoint Inhibitors – Shruti Gupta, MD, MPH

74. Mesoamerican Nephropathy – Ricardo Correa-Rotter, MD

75. Renal Ultrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD

76. Dialysis Vascular Access – Assessment and Complications – Dirk M. Hentschel, MD

77. Question and Answer Session – Faculty

78. Glomerulonephritis – Questions & Answers Session – Gerald B. Appel, MD

79. Must-Know Clinical Images in Nephrology – Ajay K. Singh, MBBS, FRCP (UK), MBA

80. Electrolytes and Acid-Base Practice for the Boards – Part 1 – Alan S.L. Yu, MB, BChir

81. Electrolytes and Acid-Base Practice for the Boards – Part 2 – Alan S.L. Yu, MB, BChir

82. Chronic Kidney Disease in the Community – Meeting Them Where They Are – Li-Li Hsiao, MD, PhD, FACP

83. COVID-19 Vaccination Response in Transplant Patients – Ann E. Woolley, MD

84. Update on Renovascular Disease – Joseph M. Garasic, MD

85. Pre-Transplant Surgical Evaluation of Recipients – Sayeed Malek, MD, FACS

86. Immunologic Basis of Kidney Disease – Vivek Kasinath, MD

87. Use of Checkpoint Inhibitors in Kidney Transplant Recipients – Naoka Murakami, MD, PhD

88. Interstitial Nephritis – Overview for the Boards – Julie M. Paik, MD, ScD, MPH

89. Ethics in Nephrology – Valerie Luyckx, MD, MB BCh

90. Pregnancy and Renal Disease – Jessica Tangren, MD

91. Transplant Cases: Board Review Practice – Melissa Y. Yeung, MD, and Edgar L. Milford, Jr., MD

92. Transplant Board Review – Anil K. Chandraker, MD

93. Must-Know Board Zebras – Emily S. Robinson, MD, MPH

94. Nephrology Board Review Practice 1 – Finnian McCausland, MB BCh, MMSc, FRCPI

95. Nephrology Board Review Practice 2 – Mallika Mendu, MD, MBA

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
error: Content is protected !!